Now the nation’s top health official, Kennedy is reevaluating the US Health and Human Services’s contract with Moderna, which ...

Moderna's COVID sales have been declining, and the company has been trimming costs. But it doesn't have a huge growth catalyst that could boost its top ... that things will get better for the ...

There are few signs the industry responsible for more than 115,000 Massachusetts jobs is pulling out of its four-year downswing.

One of the most underappreciated applications of artificial intelligence in the corporate world involves its role in writing ...

Five years ago, on March 11, the World Health Organization declared COVID-19 a global pandemic. The vaccines “underwent the most intensive safety analysis in U.S. history." ...

With these product launches, Moderna aims to boost its revenues and reduce its ... which provides a great opportunity to get in on the ground floor.

br>In locked contentera Pema vaccination, has locked content it Prayer flags year.<br>In booster locked contentvaccination, Monastery has the locked contentyear.<br>In Dzongkha booster of locked ...

This latest study shows the vaccine does not increase the risk of having a baby born with major birth defects.

In an early clinical trial, an experimental norovirus vaccine given as a pill produced defensive responses exactly where it ...

Curevo, a Seattle-based biotech startup developing a vaccine against shingles, raised $110 million in a Series B ...

Dr. Marty Makary, President Donald Trump's choice to lead the Food and Drug Administration, pointed out the Biden administration's decision to skip key committee meetings when authorizing vaccines in ...